RAI-Refractory, advanced differentiated thyroid cancer receiving tyrosine kinase inhibitor treatment: Checking for drug-drug interactions

Steven I. Sherman

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Fingerprint

Dive into the research topics of 'RAI-Refractory, advanced differentiated thyroid cancer receiving tyrosine kinase inhibitor treatment: Checking for drug-drug interactions'. Together they form a unique fingerprint.